Skip to main content
PLOS One logoLink to PLOS One
. 2023 Jul 3;18(7):e0288083. doi: 10.1371/journal.pone.0288083

Evidence from UK Research Ethics Committee members on what makes a good research ethics review, and what can be improved

Mark Sidaway 1, Clive Collett 1, Simon Erik Kolstoe 2,*
Editor: Simon White3
PMCID: PMC10317218  PMID: 37399215

Abstract

The rapid development of vaccines and other innovative medical technologies in response to the COVID-19 pandemic required streamlined and efficient ethics and governance processes. In the UK the Health Research Authority (HRA) oversees and coordinates a number of the relevant research governance processes including the independent ethics review of research projects. The HRA was instrumental in facilitating the rapid review and approval of COVID-19 projects, and following the end of the pandemic, have been keen to integrate new ways of working into the UK Health Departments’ Research Ethics Service. In January 2022 the HRA commissioned a public consultation that identified strong public support for alternative ethics review processes. Here we report feedback from 151 current research ethics committee members conducted at three annual training events, where we asked members to critically reflect on their ethics review activities, and to share new ideas or ways of working. The results showed a high regard for good quality discussion among members with diverse experience. Good chairing, organisation, feedback and the opportunity for reflection on ways of working were considered key. Areas for improvement included the consistency of information provided to committees by researchers, and better structuring of discussions by allowing signposting of the key issues that ethics committee members might need to consider.

Introduction

Research is a progressive endeavour. Systems and processes designed to ensure research, and researcher, accountability must be agile and evolve in parallel with emerging methodology and technology. The review of research projects by Research Ethics Committees (RECs), also known as Institutional Review Boards (IRBs) in some countries, is one important element of ensuring research accountability [1]. There is an increasing literature that critically examines the activities of RECs by considering issues such as consistency [2], the overall reviewing remit of committees [3], and how they integrate with research governance activities [4]. This reflection on the role and function of committees was accelerated during the COVID-19 pandemic due to the intense pressure on all parts of the research system to produce medical and technological solutions in record time [5]. Previous work on research waste (where research activities do not lead to published results) have highlighted how lengthy ethics or approval processes can hinder productive research [6], and thus it has been important to record and reflect on the solutions developed during COVID-19 to see if they can be applied more widely.

The Health Research Authority (HRA) coordinates and standardises regulatory practice across the UK for all research falling under Clinical Trials Regulations (alongside the Medicines and Healthcare products Regulatory Agency), or more broadly involving the UK’s National Health Service (NHS). Within England (there are separate REC arrangements for Scotland, Wales and Northern Ireland) the HRA’s Research Ethics Review Service appoints and coordinates 60 to 70 RECs [7]. These are constituted by up to fifteen members composed of those with professional medical or medical research experience (designated “expert” members), and at least a third who are designated as “lay” members with no such direct professional experience. Four to six applications are reviewed at monthly meetings conducted online in accordance with policy and standard operating procedures provided by the HRA. An “Ethics Review Form (ERF)” is also provided with headings [8] that RECs are expected to consider when reviewing a project.

In order to develop their policies and further improve ways of working, the HRA regularly consults widely among the research community, ethics committees and society more generally. Following the 2020/21 SARs-CoV-2 pandemic, the HRA established the “Think Ethics” programme to consider whether the pandemic had highlighted any new policies and/or ways of working that might be needed, and if so to consult on possible changes [9]. This project was consistent with similar reflections by many others within the UK and international research environment following the pandemic experience [1012]. Among the first activities conducted by the HRA was a public dialogue exercise in January 2022. This recorded four main findings [13]:

  1. that there is widespread support for alternative ethics review methods

  2. the importance of diversity within RECs so as to promote inclusivity and diversity within research participation

  3. a need for increased visibility of the activities overseen by the HRA including REC review

  4. ongoing ethical monitoring of research beyond the current, initial, approvals process

The findings from this public dialogue exercise suggested an appetite for changes to the ethics review process, but the opinion of public contributors do not represent the opinion of those experienced in the practicalities of conducting research ethics reviews, or indeed the research community itself. It was therefore important for the Think Ethics programme to consider the views of REC members alongside the public opinion.

As a public authority tasked with overseeing RECs, the HRA does regularly collect feedback from committee members through processes such as the “Shared Ethics Debate” [8], but for the purposes of the Think Ethics programme additional focus groups were held to explore the issues raised by the public dialogue exercise. These were organised as one of a number of activities held during annual face to face “REC members’ development days”. The development day format was new to the HRA and their committees in 2022, based on the pandemic forcing the majority of REC meetings online via video conferencing software. While this online reviewing arrangement has been found to work well for the ethics review of projects themselves (representing a major new way of working discovered due to the pandemic), the HRA was keen to act on feedback from REC members asking for the opportunity to meet other members face to face at least once a year to discuss relevant topics. In 2022 the topics under discussion included updates from HRA staff, a presentation on how to support adults with capacity or communication difficulties in the consent process, a presentation on updates to clinical trials legislation, and a session entitled “Think Ethics” run by the authors, as a reflection on current ways of working, along with an opportunity to raise new ideas for the conduct of ethics reviews. Here we report our findings from these latter sessions.

Materials and methods

Ethics review

The work described here was conducted as part of ongoing service improvement by the Health Research Authority and carried out by the authors as part of their normal employment. It therefore did not require an ethics review in accordance with the UK’s governance arrangements for Research Ethics Committee’s policy (section 2.3.13 & 2.3.14) [14]. As all data was recorded anonymously specific consent was not required under data protection legislation, although all participants were verbally informed as to the purpose of the session, and the fact that data would be collected, analysed and published.

Setting/Participants

Data was gathered during three one hour sessions held at REC members development days in Birmingham (8th September 2022, 37 REC members present), Reading (20th October 2022, 52 REC members present) and London (24th November 2022, 62 REC members present). Attendance data, including which REC regions were represented, was gathered by the HRA and shown in Table 1.

Table 1. REC participants at each of the three member development days.

Birmingham Reading London TOTAL
REC members 31 42 49 122
REC Officers (Chairs, Vice-Chairs & Alternate Vice-chairs) 6 10 13 29

Design/Procedure

Our design can broadly be considered a consultation exercise, with participants split into groups of six to ten REC members (including a mix of committees) and, following a brief ten minute introduction to the “Think Ethics” programme, asked to discuss the following five questions under the heading “Reflecting on our ethics reviews”. The questions were chosen following discussion among the authors with input from the HRA training team, and were designed to elicit discussion and reflection within the groups (so similar to a semi-structured focus group):

  1. How do we get to our ethics opinion?

  2. What are the most important questions to ask?

  3. What is the purpose of the ethics review form (described below)?

  4. Are there different ways of reaching this opinion?

  5. How do we satisfy ourselves that we have done a good job?

Discussions were allowed to flow freely for approximately 30 minutes with a note taker in each group (most often a HRA member of staff) summarising the discussions in the form of bullet points. A twenty minute feedback exercise was then conducted allowing each group to state their main thoughts and conclusions to the whole room. Summary notes from this latter session were also recorded by one of the authors, again as bullet pointed notes. As each of the three sessions were conducted in large conference rooms it was not possible to make audio recordings. All quotations referenced in the results are therefore summarised notes rather than a verbatim record of original statements (see limitations section).

Analysis

Following the REC members development events, the bullet pointed notes from each group, and notes from the final feedback sessions, were combined under the five questions as above (note takers were asked to format their notes under these headings). In order to analyse the data, and mindful of the spectrum of methodologies that can be used to analyse such data [1517], a content analysis method similar to recent work considering improvements in REC/IRB reviews [18] was chosen which included both a quantitative element (number of statements coded to each category) and subsequent reflexive consideration of both the identified categories and subsequent statements therein. To do this two separate researchers initially read through the data individually, creating codes/categories assisted by the NVivo [19] software. Consensus codes/categories were then agreed in discussion between the two researchers, along with the statements that were included in each category. The coded data can be found in the S1 Data. It must be reiterated that statements referred to in the results are not verbatim, but rather represent summarised bullet points made by the note takers.

Results

Tables 1 and 2 describes the participants and their REC regions, demonstrating a good geographic spread across England. Note East of England, North West and Social Care REC numbers were combined due to low numbers and to preserve anonymity.

Table 2. Representation from different REC regions.

REC region Number of Members Present
East Midlands 16
East of England, North West and Social Care REC 10
London 51
South Central 40
South West 13
West Midlands 21

Question 1: How do we get to our ethics opinion?

There were 75 statements linked to this question (by note takers) that were subsequently coded to 14 categories or sub-categories (see Table 3). Six references were coded to more than one category giving 81 references overall. By far the most common category was the role of discussion of research proposals during the REC meeting, with six comments referring to the role of the “lead reviewer” (a committee member who takes responsibility for introducing a study) and a number of further comments on the importance of the REC chair in leading the discussion. There were mixed views as to whether face to face or online formats assisted the discussion, however, all the comments under this category viewed having a discussion as a positive aspect of the review process. The importance of listening to other members, and the observation that consensus was commonly reached, was also notable. Use of the online ethics review form (ERF), which suggests ten domains to be considered when conducting an ethics review, was the second most common category, again with all comments positive (see results for question 3 for a more detailed description of the ERF). Members also reported that they tended to focus on the participant information, research design and ethical theory (in terms of “Principlism” or “Deliberative Theory”), while practicalities such as trying to be consistent and proportional were also made.

Table 3. Categories emerging in answer to the question 1: How do we get to our ethics opinion?.

Name References
Consistency 5
Ethics Review Form 10
Focus on Participant Information 7
Focus on Recruitment 1
Focus on Research Design 6
Focus on theory 6
    Ethics Domains 1
    Risk/Benefit 4
Importance of Discussion 23
    Lead Reviewer 6
    Role of REC chair 3
    Zoom vs F2F 5
Patient & Participant Views 1
Proportionate Approach 3

Question 2: What are the most important questions to ask?

There were 63 responses to this question, and once coded (Table 4) almost a third or references related to questions about risk and safety. The second most common category were questions directly relating to the design and justification of the research including whether it was articulated in a way that REC members could understand. There was also a number of acknowledgements, and apparent confusion, as to the difference between an “ethics” review and a “scientific” review, and the role of other regulators such as the Medicines and Healthcare products Regulatory Agency (MHRA) whose role is specifically to look at safety and methodology e.g.

Table 4. Categories emerging in answer to the question 2: What are the most important questions to ask?.

Name References
Consistency & Clarity of Information 6
Consistency of Review Process 7
    Different Perspectives 3
    Role of Chair 1
Participant Information & Consent 9
    Participants Perspective 5
Recruitment Strategy 1
Research Design & Justification 11
Researcher’s attitude & experience 5
Risk & Safety 19

Is poor research design a material ethical issue?

how much science to scrutinise, how much is the MHRA concern?

does the study answer the research question—fundamental. Doing something that isn’t going to produce a valid good result is pointless”

Checking the clarity of the participant facing information was also a distinct category, linked with the idea of trying to look at the information from the participant’s perspective, therefore ensuring it is clear and understandable to the “lay” person. Two categories relating to consistency were also raised, firstly the consistency of the information presented to the REC by the researchers, and secondly consistency of the questions that the committee considered, with a concern that committees need to stay focussed on fundamental issues, rather than being distracted by minor issues (such as phraseology). There were also a few comments on the importance of having a diverse committee and the value that could bring:

The broad range of views and opinions on the REC, the group variety makes for good ethical decisions. You look at studies from many different angles. For example, a lay member could ask an obvious question that has not been asked or assumed.

Question 3: What is the purpose of the ethics review form (ERF)?

The ethics review form (ERF), referred to by some as the “Lead Reviewer’s Form”, was originally a paper document appended to study documents by the HRA, but sent only to one or two REC members so that they could act as lead reviewers. It contained ten areas that the REC should consider when reviewing studies. These areas were developed over a number of years by the HRA (and its predecessor organisations) and were summarised by the National Research Ethics Advisors Panel, as described in reference [8]. As documents are now provided entirely online via the “HRA Assessment Review Portal” (HARP) system, the ten headings from the original ethics review form have been added as a tab associated with each study, with all members now able to access and add comments online (see Fig 1). The collated comments can be downloaded and used during the REC meeting, most often led by the lead reviewer or chair working their way through the headings.

Fig 1. The ethics review form tab on HARP.

Fig 1

There were 55 references to the ERF (see Table 5) with the most common being that the form assisted in the review process by helping to structure discussions or subsequent minutes, and perhaps aid consistency:

Table 5. Categories emerging in answer to the question 3: What is the purpose of the ethics review form?.

Name References
Conflict between documents 7
Helps new members 1
New section 2
Not everyone uses it 8
Prepare for meeting 11
Structures or Shortens review 18
    Right topics 3
    Wrong topics 5

a good way to structure the conversation. It’s important to raise the issues. Consistency.

There were eight references in total discussing whether the headings were either suitable (3 references) or not (5 references). The second most common category was to the form being very useful when preparing for meeting (11 references) along with being helpful for the HRA staff who are managing the meeting:

This is used to communicate with other members before the meeting and stimulate discussion.

There were eight references noting that not all members use it, and a further seven commenting that its structure does not align particularly well with application forms or study documentation provided by the researchers.

Question 4: Are there different ways of reaching this opinion?

There were 22 references under this question (Table 6) with the most common being to note that different REC members approached reviewing studies in different ways such as starting with the participant information sheet (PIS) rather than the ethics application form or protocol:

Table 6. Categories emerging in answer to the question 4: Are there different ways of reaching this opinion?.

Name References
Difference between members 3
    Co-opting members 1
    Different backgrounds 1
Different approach to documents 7
Structure of discussion 7
    Role of Chair 4

Some people start with the PIS (as if they were a participant), rather than the protocol.”

Another seven references related to the way discussions were structured or flowed noting that the lead or second reviewers were important for leading discussions, and a further four references commenting that the committee chair is quite influential:

Different chairs, different methods. Chairs ask, tell, lead reviewer does this, group discussion and occasionally voting if it comes to it.

These categories seem related to the five references commenting that members’ background and experience affects how they approach the studies and discussion.

Question 5: How do we satisfy ourselves that we have done a good job?

This question generated the most feedback with 44 distinct comments coded as 47 references (Table 7). The most common category (15 references) was the importance of receiving feedback from researchers, the HRA or other committee members, with a further five references commenting that committees try to reflect or evaluate on their own workings, including how the conversations went with the researchers:

Table 7. Categories emerging in answer to the question 5: How do we satisfy ourselves that we have done a good job?.

Name References
Committee reflection 5
Comparison with other RECs 3
Confidence from talking to researchers 3
Feedback from stakeholders 15
Reactive/evolving process 1
Reassurance from contribution of other members 4
Seeing changes proposed 1
    Seeing changes to protocols 2
Seeing outcomes of research 5
Site inspection 1
Timely & Efficient process 4
Very few research disasters 3

At the end of the REC meeting, do a wash up session—did we do a good job or do we feel weary?

And:

Was it a good interaction with the applicant, was there good dialogue?

There also seemed to be confidence in the system/processes of review such as the varied membership of committees (4 references), and the management of the committees by the HRA including time management and the efficiency of the process, although the absence of breaks was noted.

There was also a feeling of reassurance that came from seeing or hearing about the results of high quality, useful, research, and the fact that there are very few problems reported with studies that have been reviewed by the RECs:

The system is not broken. The RECs have reviewed 1000s of studies. There have been few if any disasters post REC review. There is always scope to reflect and improve the reviews, but the system is not broken and does not need to be replaced.

Discussion

This consultation exercise represented a valuable opportunity to hear directly from REC members as to how they perceive their work, and what they think could be improved. While stakeholders such as researchers are often keen to see REC review streamlined as much as possible [20], and the earlier Think Ethics public consultation indicated public support for reviewing ways of working, in general the REC members who contributed to this exercise were satisfied that their committees were doing a good job of conducting ethics reviews. The evidence described here is helpful to draw out why REC members think this to be the case, but also to guide future evidence-based improvement. While specifically relevant to HRA coordinated RECs in England, these findings are also broadly applicable within other contexts such as University RECs that often follow the extensive guidance and principles established by the HRA and promulgated through its website. Indeed within an international context, it is worth noting that the HRA network of RECs is the most extensive in the world, and thus more should be done to share their findings more widely in support of smaller, or less well coordinated, REC/IRB systems.

Perhaps the first generalisable finding from this work was that good quality and well-structured discussions within committees are key to high quality ethics reviews, and while there were plenty of comments relating to why high-quality discussions were not always achieved, the need to both promote (perhaps through training) and support (perhaps through improved ways of working) such discussions was clearly highlighted. Here the UK’s advantage of having a national system can clearly be seen as such training can be incorporated into the existing programme of REC member support as implemented by the HRA. Our results indicate that the content for such training could focus specifically on the role of either chairs or lead reviewers in leading the discussions, the way that expertise (either scientific or lay) is able to feed into such discussions, and how discussions are structured. This latter point fits closely with comments relating to the Ethics Review Form (ERF), and also answers to question three as to how the ERF is specifically used. While the headings were broadly seen as helpful (covering broad issues like scientific justification, consent process, dissemination plans etc, see Fig 1), the format of the form was viewed as problematic by some, and likewise the inconsistent approach between committees, and even members on the same committee, was highlighted. More work could therefore be done to improve the way that the ERF is used.

A second major theme coming out of this work relates to how information is presented to committees, and inconsistencies between documents. RECs are well known for combing through documents in detail, particularly participant information sheets, to pick up inconsistencies some of which are not always particularly relevant to the ethical acceptability, or otherwise, of the proposed research [8]. However, inconsistencies are very relevant if they occur within the protocol, or between the protocol and participant information/consent documents, as they might lead to confusion both within research teams as they conduct the work, and for participants who could potentially be misled as to what they are being asked to do (and critically consent to). Discovering and highlighting these ethically relevant inconsistencies is an important role for the REC, but not helped if the review documentation is provided in a piecemeal fashion using poorly structured templates. Here the discrepancy in how information is presented between protocols, the ethics application form and particularly the ERF form was highlighted. Given that all three documents aim to present and/or capture similar content, one improvement could be the harmonisation of the templates to ensure information such as study justification, study methodology, recruitment processes, risks to participants etc. are presented in roughly the same order. While the complexity and diversity of study designs must also be acknowledged, along with inconsistencies in the way that individual researchers may approach and write about their own specific protocols, more could be done from an administrative perspective to force as much consistency as possible in terms of the information is presented to REC members.

A third important issue emerging from this work was how committee members viewed themselves and their role. The UK wide Governance arrangements for research ethics committees (GAfREC) [14] define the membership of committees to allow for a sufficiently broad range of experience and expertise so that the rationale, aims, objectives and design of the research proposals can be effectively reconciled with the dignity, rights, safety and well-being of the people who are likely to take part. However, as not all members can attend every meeting, the actual composition of the REC at any single meeting may vary, thus subtly changing the balance of views brought to bear on any application under review. Likewise, previous work has shown that discussions can stray into overly scientific or medical areas rather than focussing on key ethical issues [8]. Here answers to question 4 (Are there different ways of reaching this opinion?) were particularly informative as they demonstrated that committee members do have an appreciation of the different perspectives that members from different backgrounds bring, and that they do often rely on each other for picking up different aspects of the review. Diversity is therefore important within committees. However, it is unclear as to how this diversity in approaches (and topics) considered by individual members may relate to broader issues around cultural and social diversity. For example, REC diversity data collected by the HRA [21] clearly indicate a predominantly female (62%) and older (70% above 55) demographic with lower representation from African, Caribbean, and Arab ethnicities in particular. Likewise GAfREC [14] states that a “REC should contain a mixture of people who reflect the currency of public opinion (‘lay’ members), as well as people who have relevant formal qualifications or professional experience that can help the REC understand particular aspects of research proposals (‘expert’ members)”. However, while the breadth of experience is clearly important, all REC members must also be able to read and understand at least basic scientific ideas and terminology so that they can take part in the discourse that is central to the REC review process. As a consequence, the role of Patient and Public Involvement and Engagement (PPIE) has increasingly been viewed as another central, and complementary, aspect of research review [22] alongside the parallel reviews provided by other more specialist governance/regulatory reviews (such as provided by the MHRA) and scientific peer review. It was therefore very reassuring to find that the importance of the PPIE was indeed picked up as a category under question 2 (What are the most important questions to ask?) where REC members were particularly reassured when they saw good PPIE. This observation highlights the importance of having a better understanding of what it means for a REC to ‘reflect the diversity of the adult population of society’ and ‘current ethical norms in society as well as their own ethical judgement’ (as required by GAfREC) and how this facilitates robust ethics review, and the diversity required across the research process as a whole (incorporating REC, PPIE and other reviews).

The answers given to question 5 (How do we satisfy ourselves that we have done a good job?), were also very interesting. Direct feedback from stakeholders such as researchers (often through direct interaction with the committee as they attend virtual meetings), and from the HRA itself, seemed to provide a straightforward and obvious means of validating a committee’s activities. It should also be noted that the HRA regularly ask for, and pass on, any further written feedback from researchers. However, perhaps more interesting was the way committee members were able to reassure each other, and also the way that members enjoyed co-opting on to other RECs and so being reassured that their REC was operating in broadly the same way as others. Indeed one interesting consequence of moving to an almost exclusively online meeting structure due to the COVID-19 pandemic, has been the break between geographic location and the REC that members are able to contribute to. As can be seen in Table 2, RECs are predominantly still based in geographic region, and attendance at the REC training days used for this project also indicated that members from specific committees are also still predominantly located close by. Over time as membership changes and travel is no longer a relevant concern, it might be anticipated that a more distinct break between geography and committee membership might be seen perhaps eventually even necessitating the renaming of committees, although the needs of researchers (and their familiarity with certain committees) would also need to be considered should this sort of decision ever be made.

Limitations

As with all qualitative research the results are descriptive of the views of the people in the room, and in this case as all participants were active, and volunteer, REC members, it is likely that they provided a more positive view of REC performance compared to if this exercise had been conducted with other groups. Furthermore, multiple note takers were used to summarise the statements originally made by the REC members, meaning that all the data analysed here has been subject to interpretation by the note takers who were mostly administrative members of HRA staff. However, given the consistency between the notes that we received, it seemed that rather than adding anything to the original comments, the main problem that this introduced was more likely linked to missing contextual information for the sake of brevity. For instance noting single words like “risk” or “consistency” without the wider context of how these issues were actually discussed at the time. Given this potential ambiguity, we have been careful in our analysis to only group comments under the specific question headings as given to us by the note takers, despite the fact that some comments could potentially have applied to multiple questions. However, it was reassuring to see similar categories picked up across the three separate events, and we have tried to consider overall themes emerging from all five questions in our discussion.

Conclusions

It is worth noting that although there is a considerable literature considering how RECs review studies [23, 24], this literature is seldom explicitly read or referenced by the members of committees who often “learn on the job”. As a consequence, the observations recorded in this study represent a useful summary of how existing members currently perceive their role, and ways that the processes linked to ethics review could be improved from the perspective of those actually conducting the reviews. It is also important to note that in light of technology, policy and administrative processes always changing, and especially following the COVID-19 pandemic experience, this work provides timely guidance that can be used to guide future improvements for the HRA RECs that can be expanded to other regulatory contexts. These improvements might include:

  1. Training on how to have a constructive discussion within committee, potentially facilitated by a structured Ethics Review Form (ERF) or similar.

  2. Ensuring that the structure and order of documents submitted to RECs are consistent both in terms of the types of documents submitted for each study, and the internal consistency of all documents relating to a specific study.

  3. A continued effort towards greater diversity among committee members, and where this is not possible a strengthened requirement for “Public and Patient Involvement and Engagement”.

  4. Regular feedback to committees on their performance.

Supporting information

S1 Data

(ZIP)

Acknowledgments

The authors wish to thank the members of research ethics committees who contributed to the discussion, and support from Janet Messer, Jonathan Fennelly-Barnwell and Reshma Raycoba at the Health Research Authority.

Human subjects research

The data collection described in this manuscript was performed as part of service improvement work by the Health Research Authority and therefore did not require an ethics review in accordance with the UK’s Governance Arrangements for Research Ethics Committee’s policy (section 2.3.13 & 2.3.14) [14].

Data Availability

The raw data, grouped into categories, is included in the Supporting Information.

Funding Statement

The work described here was conducted as normal duties for MS and CC as part of their employment with the Health Research Authority (HRA). SEK was seconded to the Health Research Authority to conduct this work, and was remunerated through the University of Portsmouth. As employees of the HRA this work was designed, and data collected, by the funder, however the analysis, decision to publish and preparation of the manuscript was conducted independently.

References

Decision Letter 0

Charlotte Lennox

27 Mar 2023

PONE-D-23-04580

Evidence from UK Research Ethics Committee members on what makes a good research ethics review, and what can be improved.

PLOS ONE

Dear Dr. Kolstoe,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

We have now received one review for your manuscript, but have been unable to secure a second.  So as not to delay the process any longer, as Academic Editor I have also undertaken a review. You will notice that I have focused on the introduction as I feel that the reviewer has clearly detailed the changes required to the other sections of the manuscript. 

Overall the manuscript needs significant revision to make it clear and understandable for a reader not an expert in the UK HRA and REC process. Related to this the discussion contains interpretation that appears to be based on expert personal reflections, rather than embedded within the relevant literature, and this needs addressing in the revisions. As highlighted by the reviewer the method section needs a major rewrite to include all the usual features of a methods section. 

Please submit your revised manuscript by May 11 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Charlotte Lennox

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following financial disclosure: 

    "The work described here was conducted as part of the normal duties of MS and CC as part of their employment with the Health Research Authority. SEK was seconded to the Health Research Authority to conduct this work, and was renumerated through the University of Portsmouth."

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." 

If this statement is not correct you must amend it as needed. 

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

3. Thank you for stating the following in the Competing Interests section: 

    "MS and CC work for the UK Health Research Authority. SEK was seconded to the HRA to conduct this research, and is also chair of the Cambridgeshire and Hertfordshire Research Ethics Committee. SEK is also a trustee of the charity UKRIO."

Please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials, by including the following statement: "This does not alter our adherence to  PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests).  If there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared. 

Please include your updated Competing Interests statement in your cover letter; we will change the online submission form on your behalf.

4. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. 

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

5. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. 

6. We note you have included a table to which you do not refer in the text of your manuscript. Please ensure that you refer to Table 1,4, 6 and 7in your text; if accepted, production will need this reference to link the reader to the Table.

Additional Editor Comments:

Introduction

Line 60 - RECS should be RECs

Line 67 - for a wider readership some more context is needed on 'Think Ethics', why was it established? What was the evidenced rationale for it? Is there a wider literature to support this, perhaps from other countries?

Line 70 - the four main findings need some additional detail as they lack clarity for example 'widespread support for alternative ethics review methods', how widespread, what alternative methods are being suggested - please add further details

Line 77 - If public contributors are not always familiar or experienced with/in the practicalities of conducting research ethics reviews, or indeed research itself - then the question is why was this public dialogue undertaken? It seems there is a level of assumed knowledge needed from the reader about the HRA.

Line 82 - ongoing projects seeking the opinion of REC members - such as? What's the rationale for focusing on this one in particular?

Line 83 -“REC members’ development days” - what are these?

Line 84 - These events were new to the HRA and their committees in 2022 - It is unclear which events are being referred to here. I am aware that training days for REC members existed even before the HRA existed, so would have assumed that a provision for REC members to come together existed under the HRA, prior to the pandemic - is this not the case? Perhaps some more detail of how the RECs operate and training etc is needed for the reader.

Line 91 - are the list of topics under discussion of relevance to the results? If not, you might want to remove this.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is an important topic area, and I am pleased to have been given the opportunity to review this manuscript.

I am in support of publication of this manuscript, subject to revision. At present the manuscript contains insufficient methodological information and the results section requires more synthesis and detail.

Please see my comments by section below.

Abstract

Line 39-37 It is unclear how ‘attending 37 annual training events’ is relevant here. Data were collected at 3 events.

Introduction

Line 49 State ‘Research Ethics Committees’ in full before using (REC).

Line 56 It would be helpful to define ‘research waste’.

Lines 60+ It would be useful here to provide an overview of the HRA review process. E.g., who are applicants, types of studies that require REC approval (as opposed to HRA only), panel members, role of the chair, use of ERF system etc. This will be common knowledge for most UK researchers who recruit via the NHS but not for those who don’t, or international readership, whose processes are likely to vary.

Material & Methods

Lines 100+ Most elements of a traditional methodology section are missing, namely headings and information related to: design, setting/participants, materials, procedure, analysis. Please reformat to ensure that all key elements of the methodology are present, clear, and replicable.

More information is required re. group facilitation and note taking. It is unclear why audio recording was not utilised so this should be considered as a limitation of the methodology.

The nature of the note taking needs for description. Exactly what was noted? Was this verbatim or summarised in the researchers’ words?

Line 125 A full description of the process of content analysis is required. I also note that this method of analysis is not supported by a reference. Which form of content analysis was used?

It is unclear how consensus themes were formed when analysis was conducted following two different procedures (NVivo/manual) – please provide more information. It is also unclear what manual means.

Results

Table 1. Best practice would be to collapse representation categories by region only, not by individual REC. For some RECs you have just 1 representative. Whilst it is unlikely that individuals’ can be identified, knowing that 1 member from a particular panel participants allows for process of elimination.

It is also unclear how these data were obtained as the methodology does not provide an overview of this data capture.

Line 134+ I note that much of the text here relates to respondents mentioning the procedures that underpin the ethical review process but not what your respondents perceived as facilitators/barriers to making ethical decisions. My assumption is that there is more context within the response data re. why the discussion is important, the importance of ‘consistency’, weighing up risk/benefit etc. I recommend revisiting the data and trying to provide a richer overview of the responses.

Line 136 Careful with use of terminology such as ‘theme’. We would expect this term to be referenced in a thematic analysis less so in a content analysis if this type.

Table 3. The theme names here provide little information without also containing a definition of the theme and/or a response example (this comment is relevant to all other theme tables.)

Line 157 ‘it was interesting’ – best practice is to avoid commentary/interpretation and state findings factually in the results section.

Line 162 The MHRA process will be unknown to most researchers. I think this highlights why it is important to provide an overview of the REC remit in the introduction, including its joint role with other agencies (e.g. MHRA, HMPPS etc.)

General comment:

As with my comment for Question 1, I imagine there is a lot more to unpack here other than respondents mentioning the same thing. What is it about these things that the respondents deemed important? E.g., ‘checking the clarity of the participant facing information was also a distinct theme’ – why? I also note that theme headings appear to overlap between Questions 1 and 2. I wonder if some further analysis is required here to move responses to the appropriate question? It is usual for respondents to provide comments to a question which are more relevant to a subsequent question.

It is accepted practice to re-group data where appropriate.

For example, I see ‘role of chair’ is a theme in Q2 but I imagine this response is more relevant to Q1.

Line 167-168 ‘a concern that committees need to stay focussed on fundamental issues, rather than being distracted by minor issues’ – this information is difficult to interpret if the reader does not understand the ethical review process (i.e. contentious ethical issues are discussed at panel and applicants receive comprehensive feedback on these and other minor issues in writing – this would be useful in the introduction).

Like 172 -174 This is presented as though it is a quotation, yet it is a researcher summary of responses, it should be clear that this is the case (this comment is relevant to all comment excerpts).

Lines 180-190 I see the ERF information is provided here which is great. I still recommend a simple description in the introduction, considering the ERF is mentioned in a previous question response.

201-202 What was/wasn’t seemed as useful about the headings?

Discussion

General comment:

There is much more detail provided re. the findings in the discussion than in the results section, where we should expect to see much of this summary (see comments about detail above). It would be useful to present the more of the discussion within the context of the literature base. My assumption is that the authors are very experienced REC members and much of the interpretation is personal reflection. It might be helpful to at least refer to REC terms of reference or policy documents when referring to process (assuming these are publicly accessible).

Line 329-333 Reference missing for these findings.

General comment:

Much of the discussion provided in the latter part of this section contains important information to aid HRA developments. However for a manuscript of this type I would expect to see application of these findings to policy for RECs in general. Are you able to apply these findings to other agencies E.g., university RECs, HMPPS, international agencies?

Line 374+ Please consider other limitations, e.g., the nature of the data collection.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Jul 3;18(7):e0288083. doi: 10.1371/journal.pone.0288083.r002

Author response to Decision Letter 0


17 Apr 2023

17th April 2023

Dear Dr Lennox,

Thank you for arranging the review of our manuscript:

PONE-D-23-04580 Evidence from UK Research Ethics Committee members on what makes a good research ethics review, and what can be improved.

Peer review of a manuscript can sometime be a frustrating process, however in this case we were really appreciative of the constructive comments as they helped us to think carefully about this manuscript and what we are trying to present.

For some context, it is an interesting facet of research ethics review that committees are coordinated by administrative and/or regulatory authorities whose main aims is policy compliance and efficiency rather than academic transparency in the form of publications. As a consequence, despite the significant amount of work that goes into improving processes, the results are seldom released publicly as they instead take the form of updated standard operating procedures, guidance etc. that are seldom communicated in any meaningful way outside the organisation involved. This is a real weakness in the research system because organisations such as the UK’s Health Research Authority have considerable experience in research ethics review that is not well communicated.

To address this the aim of this paper was to take a really interesting piece of work conducted by the HRA as a service improvement activity, and try to make it more available for the wider research ethics community. The work was therefore not originally designed as a research project, and thus certain components – such as holding independent focus groups that could be recorded and transcribed – were not possible. However, despite these limitations, our aim was to turn what might have otherwise been a purely administrative (and potentially soon forgotten) project into a robust data collection and analysis that will hopefully meet the standard, and be of interest, to the literature and thus wider community.

The following describes our response to the review with reviewers comments in italic, and our comments marked in green (on submission we were asked to upload an unformatted version of this letter, but we note a version that retains the colours was included at the bottom of the pdf file).

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

This has been done.

2. Thank you for stating the following financial disclosure:

"The work described here was conducted as part of the normal duties of MS and CC as part of their employment with the Health Research Authority. SEK was seconded to the Health Research Authority to conduct this work, and was remunerated through the University of Portsmouth."

Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

If this statement is not correct you must amend it as needed.

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

The following is our revised funder statement:

“The work described here was conducted as normal duties for MS and CC as part of their employment with the Health Research Authority (HRA). SEK was seconded to the Health Research Authority to conduct this work, and was remunerated through the University of Portsmouth. As employees of the HRA this work was designed, and data collected, by the funder, however the analysis, decision to publish and preparation of the manuscript was conducted independently.”

3. Thank you for stating the following in the Competing Interests section:

"MS and CC work for the UK Health Research Authority. SEK was seconded to the HRA to conduct this research, and is also chair of the Cambridgeshire and Hertfordshire Research Ethics Committee. SEK is also a trustee of the charity UKRIO."

Please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials, by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests). If there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared.

Please include your updated Competing Interests statement in your cover letter; we will change the online submission form on your behalf.

We are happy to include this additional like in the Competing Interests section so that it now reads:

“MS and CC work for the UK Health Research Authority. SEK was seconded to the HRA to conduct this research, and is also chair of the Cambridgeshire and Hertfordshire Research Ethics Committee. SEK is also a trustee of the charity UKRIO. This does not alter our adherence to PLOS ONE policies on sharing data and materials.”

4. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

[text with various options deleted]

We have now made our data available as supplementary information.

5. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well.

This has been done.

6. We note you have included a table to which you do not refer in the text of your manuscript. Please ensure that you refer to Table 1,4, 6 and 7in your text; if accepted, production will need this reference to link the reader to the Table.

This has been done.

Additional Editor Comments:

Introduction

Line 60 - RECS should be RECs

Corrected

Line 67 - for a wider readership some more context is needed on 'Think Ethics', why was it established? What was the evidenced rationale for it? Is there a wider literature to support this, perhaps from other countries?

It has been clarified that the purpose of “Think Ethics” was to act on lessons learned from the COVID pandemic. Some references to other similar work have been included.

Line 70 - the four main findings need some additional detail as they lack clarity for example 'widespread support for alternative ethics review methods', how widespread, what alternative methods are being suggested - please add further details

These four findings were verbatim quotes from the report so have now been formatted as such to make this clear. Indeed the whole purpose of the work reported here was to try to determine what the “alternative review methods” might be from the perspective of REC members.

Line 77 - If public contributors are not always familiar or experienced with/in the practicalities of conducting research ethics reviews, or indeed research itself - then the question is why was this public dialogue undertaken? It seems there is a level of assumed knowledge needed from the reader about the HRA.

This has been further clarified to state that multiple stakeholder engagements have been conducted, one of which was the public involvement exercise referenced in the introduction, and another was the consultation with REC members which is being reported in this manuscript.

Line 82 - ongoing projects seeking the opinion of REC members - such as? What's the rationale for focusing on this one in particular?

This has been clarified as above – one project was seeking public opinion, this manuscript is focusing on the project seeking REC members opinions.

Line 83 -“REC members’ development days” - what are these?

Line 84 - These events were new to the HRA and their committees in 2022 - It is unclear which events are being referred to here. I am aware that training days for REC members existed even before the HRA existed, so would have assumed that a provision for REC members to come together existed under the HRA, prior to the pandemic - is this not the case? Perhaps some more detail of how the RECs operate and training etc is needed for the reader.

Line 91 - are the list of topics under discussion of relevance to the results? If not, you might want to remove this.

The description of the REC members days has been expanded, although the final comment (regarding old Line 91) is slightly inconsistent with the earlier request to describe what these days entail – but hopefully this section now reads a bit better.

5. Review Comments to the Author

Abstract

Line 39-37 It is unclear how ‘attending annual training events’ is relevant here. Data were collected at 3 events.

This has been clarified.

Introduction

Line 49 State ‘Research Ethics Committees’ in full before using (REC).

Line 56 It would be helpful to define ‘research waste’.

Both now done.

Lines 60+ It would be useful here to provide an overview of the HRA review process. E.g., who are applicants, types of studies that require REC approval (as opposed to HRA only), panel members, role of the chair, use of ERF system etc. This will be common knowledge for most UK researchers who recruit via the NHS but not for those who don’t, or international readership, whose processes are likely to vary.

This description has been significantly expanded as requested.

Material & Methods

Lines 100+ Most elements of a traditional methodology section are missing, namely headings and information related to: design, setting/participants, materials, procedure, analysis. Please reformat to ensure that all key elements of the methodology are present, clear, and replicable.

Headings have been added, and care taken to ensure that the description is sufficient to allow another research team to replicate the activities described here.

More information is required re. group facilitation and note taking. It is unclear why audio recording was not utilised so this should be considered as a limitation of the methodology.

The nature of the note taking needs for description. Exactly what was noted? Was this verbatim or summarised in the researchers’ words?

The method used has been expanded and the consequent limitations described more fully. However, as noted in the introductory paragraph of this letter, this manuscript is reporting on an activity originally designed for service improvement and not research per se, and thus while we are confident that the results are robust, we acknowledge that they do not follow standard research practice.

Line 125 A full description of the process of content analysis is required. I also note that this method of analysis is not supported by a reference. Which form of content analysis was used?

It is unclear how consensus themes were formed when analysis was conducted following two different procedures (NVivo/manual) – please provide more information. It is also unclear what manual means.

Thank you for this comment. You are absolutely correct that some confusion crept in by us referring to “themes”, so we have now significantly tidied up the results and discussion section to make sure it is clear that we conducted a content analysis and thus inductively identified “categories” of comments, rather than classified comments into pre-defined themes. We have referenced both a classic paper on the complexities of this approach alongside a very recent paper in the journal Research Ethics that conducted a similar analysis to the one we have done here. Regarding “manual coding” this was more a passing (and perhaps overly honest) reflection of trouble that one author had operating NVivo, meaning that the other researcher had to manually load all the categories into the software. Reference to this has now been deleted as despite taking a long time, it did not have any meaningful impact on the results.

Results

Table 1. Best practice would be to collapse representation categories by region only, not by individual REC. For some RECs you have just 1 representative. Whilst it is unlikely that individuals’ can be identified, knowing that 1 member from a particular panel participants allows for process of elimination.

It is also unclear how these data were obtained as the methodology does not provide an overview of this data capture.

Both done – table categories collapsed, and a line added to the methods describing how this data was obtained.

Line 134+ I note that much of the text here relates to respondents mentioning the procedures that underpin the ethical review process but not what your respondents perceived as facilitators/barriers to making ethical decisions. My assumption is that there is more context within the response data re. why the discussion is important, the importance of ‘consistency’, weighing up risk/benefit etc. I recommend revisiting the data and trying to provide a richer overview of the responses.

I think this reflects the challenges of this type of data collection and analysis. A significant weakness of our method (now explicitly stated and discussed) was the use of note takers who often did not provide the full context of specific comments. We have therefore tried to draw out as much as this as we can, and added a few more direct quotes from the data, but are mindful of other feedback that you have given about not using our own experience to overly interpret the data. However, should the reader be interested in trying to glean further context, the data has now been included in supplementary materials.

Line 136 Careful with use of terminology such as ‘theme’. We would expect this term to be referenced in a thematic analysis less so in a content analysis if this type.

Table 3. The theme names here provide little information without also containing a definition of the theme and/or a response example (this comment is relevant to all other theme tables.)

Have replaced all use of the word “theme” with “category” to reflect that this is a content, not thematic, analysis.

Line 157 ‘it was interesting’ – best practice is to avoid commentary/interpretation and state findings factually in the results section.

Deleted in the results, although kept a couple instances of the word “interesting” in the discussion where we feel it is more acceptable to provide interpretation.

Line 162 The MHRA process will be unknown to most researchers. I think this highlights why it is important to provide an overview of the REC remit in the introduction, including its joint role with other agencies (e.g. MHRA, HMPPS etc.)

Done

General comment:

As with my comment for Question 1, I imagine there is a lot more to unpack here other than respondents mentioning the same thing. What is it about these things that the respondents deemed important? E.g., ‘checking the clarity of the participant facing information was also a distinct theme’ – why? I also note that theme headings appear to overlap between Questions 1 and 2. I wonder if some further analysis is required here to move responses to the appropriate question? It is usual for respondents to provide comments to a question which are more relevant to a subsequent question.

It is accepted practice to re-group data where appropriate.

For example, I see ‘role of chair’ is a theme in Q2 but I imagine this response is more relevant to Q1.

We have provided some comment on this, although as mentioned, because of the limitation of using note takers we have been quite strict with ourselves in trying not to over interpret the data. As a consequence we have kept the results and initial discussion focussed purely on the data that actually came in under each heading, although our overall conclusions does take a slightly broader view of ideas that were expressed across the five questions (see point below regarding the four “actions” that the HRA will be taking away from this work).

Line 167-168 ‘a concern that committees need to stay focussed on fundamental issues, rather than being distracted by minor issues’ – this information is difficult to interpret if the reader does not understand the ethical review process (i.e. contentious ethical issues are discussed at panel and applicants receive comprehensive feedback on these and other minor issues in writing – this would be useful in the introduction).

Like 172 -174 This is presented as though it is a quotation, yet it is a researcher summary of responses, it should be clear that this is the case (this comment is relevant to all comment excerpts).

Lines 180-190 I see the ERF information is provided here which is great. I still recommend a simple description in the introduction, considering the ERF is mentioned in a previous question response.

201-202 What was/wasn’t seemed as useful about the headings?

All four points clarified in the text.

Discussion

General comment:

There is much more detail provided re. the findings in the discussion than in the results section, where we should expect to see much of this summary (see comments about detail above). It would be useful to present the more of the discussion within the context of the literature base. My assumption is that the authors are very experienced REC members and much of the interpretation is personal reflection. It might be helpful to at least refer to REC terms of reference or policy documents when referring to process (assuming these are publicly accessible).

We have tried to make the discussion a bit more factual and added some more references. However, it should be noted that as a service improvement exercise, the outcome as far as the HRA are concerned will/has been succinctly summarised in their internal report (not published externally) as being:

1) Provide more training on how to have a constructive discussion within the committee, updating the Ethics Review Form (ERF) to help guide such discussion.

2) Review the structure of study documents to ensure the material given to committees is more consistent

3) Continue working towards greater diversity among committee members, and where this is not possible strengthen the requirement for “Public and Patient Involvement and Engagement”.

4) Provide more feedback to committees on their performance.

We have therefore structured the discussion around these four points, showing how the data has led to these recommendations. Indeed as these conclusions are generalisable well beyond the HRA RECs, one big motivation for submitting this manuscript was to highlight the evidence for these so that they could be used elsewhere. We are not aware that this particular journal allows summary boxes, but would be happy to include these four recommendations in a more obvious way if the reviewer feels they are not displayed suitably. They are, however, stated in the abstract.

Line 329-333 Reference missing for these findings.

Reference added.

General comment:

Much of the discussion provided in the latter part of this section contains important information to aid HRA developments. However for a manuscript of this type I would expect to see application of these findings to policy for RECs in general. Are you able to apply these findings to other agencies E.g., university RECs, HMPPS, international agencies?

See above comment – we do think these findings are broadly generalisable across other RECs (and IRBs), and hence the reason for this paper.

Line 374+ Please consider other limitations, e.g., the nature of the data collection.

Now added as described above.

(final comment from editor):

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

This has been done and the modified figure file from the PACE tool uploaded.

We once again thank the reviewers for their comments that we do feel have genuinely improved our manuscript, and hope that it is now in a position to be published.

Yours Sincerely,

Simon, Matt and Clive.

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Charlotte Lennox

15 May 2023

PONE-D-23-04580R1Evidence from UK Research Ethics Committee members on what makes a good research ethics review, and what can be improved.PLOS ONE

Dear Dr. Kolstoe,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. We'd like to thank you for addressing the first round of comments in such detail.  The manuscript has been reviewed by the same reviewer(s) and they have identified some additional minor comments. As Academic Editor I do agree that these changes would benefit the manuscript, in terms of boosting the scientific rigor of the method and results.   

Please submit your revised manuscript by Jun 29 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Charlotte Lennox

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: I am pleased to see that the authors have gone to great effort to address my comments and make changes to the manuscript.

I have a few further comments below which can be addressed via minor revision.

Materials and methods:

I can see great improvement here. Whilst I recognise that this data collection was not intended as research activity, there are still some details missing.

• Setting/participants – participants are not described. Who attended? How many?

• Design – the activity design remains unnamed. Perhaps ‘consultation exercise’ in appropriate.

• Procedure – more details are required re. note taking procedure.

• Analysis – I note you reference Braun and Clark (15) for content analysis however the paper referenced concerns thematic analysis. Please provide an appropriate reference.

• Analysis – more detail is required re. the content analysis procedure. Each step of grouping of content should be described.

• Analysis – this section, or the beginning of the results section should state how the findings are presented and explicitly state that the quotes included are note excerpts and not verbatim participant quotes.

Results:

Line 193-195: ‘although which aspects of risk and safety were most important was difficult to assess as notes often just stated “risk” or similar one-word answers’ – I recommend omitting this sentence and instead discussing the quality of note taking as a limitation in the discussion.

Discussion:

Line 384+:

‘It is unclear whether RECs themselves should be entirely representative of society due to the technical nature of documents under review, and also the specific skills needed by members to operate within the committee review structure’.

- I understand what you are getting at here, but I feel there is opportunity for misinterpretation. A less considered reader might surmise that you think groups with particular characteristics are less likely to have the skills required.

it might be pertinent here to reflect on professional roles of REC chair and members (clinical, academic etc.) and how these professionals are not representative of society, therefore it is perhaps unsurprising that the REC panel is not representative – then move onto praising the inclusion of lay and PPIE members.

Line 223 – a conclusion paragraph would be of great value here – with recommendations for future REC practice/HRA oversite/research into the area.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Jul 3;18(7):e0288083. doi: 10.1371/journal.pone.0288083.r004

Author response to Decision Letter 1


23 May 2023

(Please note: a version of this letter with formatting can be found in the pdf version of this submission as it is difficult to distinguish between the reviewers requests and our responses without formatting)

Dear Dr Lennox,

Thank you for the feedback requesting minor revisions of our manuscript:

PONE-D-23-04580 Evidence from UK Research Ethics Committee members on what makes a good research ethics review, and what can be improved.

We believe we have now addressed the final minor revisions as follows:

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

These have been checked and updated.

Reviewer #1: I am pleased to see that the authors have gone to great effort to address my comments and make changes to the manuscript.

I have a few further comments below which can be addressed via minor revision.

Thank you for your reviews and further comments that are definitely contributing to the quality of this manuscript. Much like a PhD viva it can be quite fun engaging with someone interested in our research!

Materials and methods:

I can see great improvement here. Whilst I recognise that this data collection was not intended as research activity, there are still some details missing.

• Setting/participants – participants are not described. Who attended? How many?

This is now explicitly stated.

• Design – the activity design remains unnamed. Perhaps ‘consultation exercise’ in appropriate.

• Procedure – more details are required re. note taking procedure.

Both done.

• Analysis – I note you reference Braun and Clark (15) for content analysis however the paper referenced concerns thematic analysis. Please provide an appropriate reference.

This comment took us down a rabbits warren trying to define exactly what our specific analysis should be called. We now reference two updated papers by Braun and Clark (along with their much referenced 2006 paper), where in their most recent discussion published in January this year they state:

We suggest that a relativist approach to quality facilitates rigour, through requiring a thoughtful and knowing researcher, who engages and reflects, considering quality in the context of a particular study, rather than having a checklist of universal standards to meet. (https://doi.org/10.1080/17437199.2022.2161594).

As a consequence we have focussed on whether, within the context of our work, our analysis is robust, repeatable and the conclusions are in actual fact relevant, useful and helpful to the development of REC review. There will of course always be other ways of conducting the analysis, but we believe our approach has been suitable. We are therefore thankful for your two final suggestions relating to the analysis that we have also addressed, seeking to reinforce the description and therefore reproducibility of our approach:

• Analysis – more detail is required re. the content analysis procedure. Each step of grouping of content should be described.

• Analysis – this section, or the beginning of the results section should state how the findings are presented and explicitly state that the quotes included are note excerpts and not verbatim participant quotes.

Moving on to the results section:

Line 193-195: ‘although which aspects of risk and safety were most important was difficult to assess as notes often just stated “risk” or similar one-word answers’ – I recommend omitting this sentence and instead discussing the quality of note taking as a limitation in the discussion.

Done – second half of sentence deleted.

Discussion:

Line 384+: ‘It is unclear whether RECs themselves should be entirely representative of society due to the technical nature of documents under review, and also the specific skills needed by members to operate within the committee review structure’. - I understand what you are getting at here, but I feel there is opportunity for misinterpretation. A less considered reader might surmise that you think groups with particular characteristics are less likely to have the skills required. it might be pertinent here to reflect on professional roles of REC chair and members (clinical, academic etc.) and how these professionals are not representative of society, therefore it is perhaps unsurprising that the REC panel is not representative – then move onto praising the inclusion of lay and PPIE members.

Done – sentence deleted and the roles of expert (professional)/ lay REC members emphasised.

Line 223 – a conclusion paragraph would be of great value here – with recommendations for future REC practice/HRA oversite/research into the area.

Done – conclusions/recommendations added as in our previous letter to you.

We thank you again for these final updates to our manuscript, and hope that with these minor revisions addressed we will soon be able to see the paper published.

Yours Sincerely,

Simon, Matt and Clive.

Decision Letter 2

Simon White

19 Jun 2023

Evidence from UK Research Ethics Committee members on what makes a good research ethics review, and what can be improved.

PONE-D-23-04580R2

Dear Dr. Kolstoe,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Simon White

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Simon White

23 Jun 2023

PONE-D-23-04580R2

Evidence from UK Research Ethics Committee members on what makes a good research ethics review, and what can be improved.

Dear Dr. Kolstoe:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Simon White

Academic Editor

PLOS ONE


Articles from PLOS ONE are provided here courtesy of PLOS

RESOURCES